First Light Asset Management’s Integra LifeSciences IART Stock Holding History

First Light Asset Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,261	Closed	-$316K	–	65
2023 Q4	$316K	Hold	7,261	–	–	0.03%	64
2023 Q3	$277K	Hold	7,261	–	–	0.03%	71
2023 Q2	$299K	Hold	7,261	–	–	0.02%	73
2023 Q1	$417K	Hold	7,261	–	–	0.04%	50
2022 Q4	$407K	Buy	+7,261	New	+$370K	0.04%	49

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

First Light Asset Management's IART Position: Q1 2024 in Review

First Light Asset Management sold out of Integra LifeSciences (IART) in Q1 2024, closing a stake of 7,261 shares — an estimated $316K sold.

First Light Asset Management first reported a position in IART in Q4 2022 and held it in 5 quarters. The position peaked at $417K in Q1 2023. 281 funds tracked by Wall St. Rank hold IART as of Q1 2024.

First Light Asset Management reported no remaining Integra LifeSciences position as of Q1 2024 after selling out during the quarter.
First Light Asset Management sold 7,261 Integra LifeSciences shares in Q1 2024, an estimated $316K.
First Light Asset Management first reported a position in Integra LifeSciences in Q4 2022 and held it in 5 quarters.
First Light Asset Management's Integra LifeSciences position peaked at $417K in Q1 2023.
281 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2024.

Based on First Light Asset Management's 13F filing for Q1 2024, filed 15 May 2024.